Ligand: Q2 Earnings Snapshot

August 8, 2022 GMT

EMERYVILLE, Calif. (AP) _ Ligand Pharmaceuticals Inc. (LGND) on Monday reported a second-quarter loss of $895,000, after reporting a profit in the same period a year earlier.

On a per-share basis, the Emeryville, California-based company said it had a loss of 5 cents. Earnings, adjusted for one-time gains and costs, were 34 cents per share.

The drugmaker posted revenue of $57.4 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $39.7 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on LGND at